Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA
about
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strainsCloning and expression of the human vasoactive intestinal peptide receptorInternational Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyRecognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens.The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammationBiological role of the N-formyl peptide receptorsNovel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63Identification and characterization of an endogenous chemotactic ligand specific for FPRL2N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPRIdentification of a human cDNA encoding a functional high affinity lipoxin A4 receptorProduction of a bioengineered G-protein coupled receptor of human formyl peptide receptor 3Molecular cloning of a novel rat G-protein-coupled receptor gene expressed prominently in lung, adrenal, and liver.The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.Formyl peptide receptor expression in birds.The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptide.Conserved transducer coupling but different effector linkage upon expression of the myeloid fMet-Leu-Phe receptor in insulin secreting cells.Receptor "hijacking" by malignant glioma cells: a tactic for tumor progressionPhosphorylation of the N-formyl peptide receptor carboxyl terminus by the G protein-coupled receptor kinase, GRK2.Direct or C5a-induced activation of heterotrimeric Gi2 proteins in human neutrophils is associated with interaction between formyl peptide receptors and the cytoskeleton.Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor.Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulenceNovel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as selective agonists of human formyl-peptide receptor 2Structural and functional characterization of the human formyl peptide receptor ligand-binding regionAffinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonistA high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptorExpression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cellsIdentification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils.Functions of C5a receptors.Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.Receptor class desensitization of leukocyte chemoattractant receptors.Resolution of inflammation: targeting GPCRs that interact with lipids and peptides.Chemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoA.Rat and human neutrophil N-formyl-peptide chemotactic receptors. Species difference in the glycosylation of similar 35-38 kDa polypeptide cores.Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.Regulation of inflammation by lipid mediators in oral diseases.Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015).Formyl Peptide Receptors in Cellular Differentiation and Inflammatory Diseases.
P2860
Q24319950-31C1F944-E6D9-4DDC-B916-7AAF3E6BCA2EQ24561399-CF27837E-50DE-4B9B-A551-FBEA98A8F902Q24652940-E3810F99-C9CD-48FB-A579-9C1113A47D16Q27313685-E6BF59DD-8A47-42DB-91B6-836F5EF8BCBEQ28086841-392820DB-C8FC-413F-9725-77D2FBC76B96Q28239162-B3D96B0B-C319-4818-AAB5-06596B8C8DB4Q28294166-7F5ECABE-916E-493D-9147-D5E0F0550C7EQ28300408-DDE7B2CA-7C1A-4554-8552-118E7B39C3B4Q28343567-61A81A6C-9404-4053-BEB1-601C9C92EFE3Q28369186-E3FE9DED-565F-48CF-AA4D-B2E41CBAEEC0Q28476523-E2011A1F-BB3A-48F5-8A8D-375AAD3A5154Q30467335-6C178228-4915-4EC7-AA57-205E5881FE48Q30800519-94EF6396-5CE2-4BAE-9B72-D45DAAEC6CD5Q31132474-A7AADB01-EB8A-4B6B-8C8C-2139A101710CQ33196760-D68248FB-BE72-454E-A8B8-2DA22CC837FCQ33283002-C0F1A100-17EA-4F4C-9A57-B5D317C0A1E4Q33625498-013F8F2D-82D3-4813-A517-E6F57080BE97Q34054539-FA606CF8-4DE3-4A39-8C4C-D1704F5E6F61Q34313996-8DFE8BB2-931F-451B-AFBB-2EA6ACB26734Q34317288-F48836FB-5F65-41FA-90E4-F7BF783C0C36Q34384515-80438928-350F-44F6-90F9-FC7F7CBA3CAEQ34492932-8F12A155-5FC3-4C83-A69F-541DDAF137DFQ34682431-EFAEB4D0-B808-4C19-9B4A-D244FB5CFD24Q35738729-6A51B293-AD9C-45C6-9A9F-ED584DE0CBEAQ35779389-D2F8F60A-E182-4B8F-AC79-5FC59E53DC09Q36213478-BE10EED5-E468-42B4-8BEC-BB77249B32D5Q36232944-BBD8E0E4-9578-48F6-9CA7-3854021E5E75Q36364113-6E9D4C89-F170-4B56-B6C5-99B9DEAB3909Q36768315-9EEC42C9-10E9-425A-8D51-44B9467EC0F8Q37250080-19D97DA1-30FB-438D-AC68-5338912B936AQ37369597-8832EE22-373A-43A1-BB4E-450173A00141Q37618896-CADCA1A6-10E7-461B-94D8-A4868BB98271Q37653155-334ADAEB-9F59-4D92-AB35-289DC984931DQ38226022-C90F60A3-9EFB-4458-BA89-325DE0F4D72CQ38297271-E0F30B39-5834-45C6-BA36-A13E5D849DC9Q38334522-732D9ED4-AA29-48FA-96DE-BD95520B50C3Q38588798-BB37B317-19E3-43E2-967F-AEF78296F30EQ38899898-DF440DB0-1C07-4195-BF46-C5A1C588B9B4Q38907435-3ECE8444-33A2-4C52-95D9-386E5DABE5EAQ39079401-EDAB4DC8-C154-4835-812A-BFEFF1A99D3A
P2860
Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA
description
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1990
@ast
im Mai 1990 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1990/05/16)
@sk
vědecký článek publikovaný v roce 1990
@cs
wetenschappelijk artikel (gepubliceerd op 1990/05/16)
@nl
наукова стаття, опублікована в травні 1990
@uk
научни чланак (објављен 1990/05/16)
@sr
name
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@ast
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@en
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@nl
type
label
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@ast
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@en
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@nl
prefLabel
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@ast
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@en
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@nl
P2093
P1476
Synthesis and use of a novel N ...... N-formyl peptide receptor cDNA
@en
P2093
L. Brouchon
P. Vignais
P304
P356
10.1016/0006-291X(90)91143-G
P407
P577
1990-05-16T00:00:00Z